Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections

Microorganisms

Joana Rocha-Pereira¹  Nanci Santos-Ferreira¹  Johan Neyts¹  Jana Van Dycke¹ 

[1] Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium;

关键词: norovirus;    rotavirus;    sapovirus;    adenovirus;    astrovirus;    viral gastroenteritis;   

DOI  :  10.3390/microorganisms9081599

来源: DOAJ

【 摘 要 】

Acute gastroenteritis caused by virus has a major impact on public health worldwide in terms of morbidity, mortality, and economic burden. The main culprits are rotaviruses, noroviruses, sapoviruses, astroviruses, and enteric adenoviruses. Currently, there are no antiviral drugs available for the prevention or treatment of viral gastroenteritis. Here, we describe the antivirals that were identified as having in vitro and/or in vivo activity against these viruses, originating from in silico design or library screening, natural sources or being repurposed drugs. We also highlight recent advances in model systems available for this (hard to cultivate) group of viruses, such as organoid technologies, and that will facilitate antiviral studies as well as fill some of current knowledge gaps that hamper the development of highly efficient therapies against gastroenteric viruses.

【 授权许可】

Unknown